Clinical Trial Update: Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF [NA]

View source ↗

Summary

An update on a completed trial evaluating whether 5% povidone-iodine provides ocular-surface advantages over 1% during intravitreal anti-VEGF injections in Dry …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Povidone-iodine 1% (povidone-iodine)
• Povidone-iodine 5% (povidone-iodine)

Snippet

Sponsor: José Gerardo García Aguirre | Conditions: Dry Eye | NA | Status: COMPLETED